drugset / Trial / NCT00616694
Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the effect of subject knowledge of their disease status on persistence in subjects receiving Actonel 5 mg daily over a 12-month period for the prevention and treatment of GIO.
Timeline
- Start
- 2002-07
- Primary completion
- —
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risedronate | Small molecule | 5 mg | Oral |
| Background | Calcium carbonate | Other / unclassified | 500 mg | — |
| Background | Vitamin D | Other / unclassified | 200 iu | — |